-+ 0.00%
-+ 0.00%
-+ 0.00%

Allarity Therapeutics Q1 EPS $(0.17) Beats $(0.22) Estimate, Sales $25.000K

Benzinga·05/15/2026 20:31:34
Listen to the news
Allarity Therapeutics (NASDAQ:ALLR) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.22) by 22.73 percent. This is a 32 percent increase over losses of $(0.25) per share from the same period last year. The company reported $25.000 thousand in sales this quarter.